The U.S. Food and Drug Administration has issued a warning about possible kidney problems associated with the use of Byetta, a diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co.
The U.S. Supreme Court has asked Solicitor General Elena Kagan to weigh in on the Alien Tort Statute in a case involving pharmaceutical giant Pfizer Inc.'s medical experiments in Nigeria.
A unit of Allianz of America has gone on the offensive in a declaratory judgment suit brought by Utica Mutual Insurance Co., arguing in counterclaims filed Monday that it does not owe a disputed $25 million in reinsurance coverage stemming from thousands of underlying suits over asbestos contamination.
A District of Columbia appeals court has kept a case against Motorola Inc., Verizon Wireless Inc., AT&T Corp. and others alive, reversing in part a lower court's decision to dismiss consolidated suits claiming older phones emitted dangerous amounts of radiation.
A federal appeals court has ruled that a judge rightly threw out a $27 million award to a woman who claimed Wyeth and a Pfizer Inc. subsidiary failed to warn about the cancer risk of their controversial hormone replacement treatment because of expert testimony the judge said should not have been allowed.
Wood composite materials maker Advanced Environmental Recycling Technologies Inc. has sought to appeal a ruling that an American International Group Inc. affiliate does not owe any defense coverage for claims that the company’s products are defective and vulnerable to unsightly mold and fungal growth.
A group of consumers has asked a federal judge to certify three classes — each of which would purportedly consist of at least 10,000 people — in a lawsuit accusing Wal-Mart Stores Inc., Zoller Laboratories LLC and others of making fraudulent claims about weight loss products Zantrex-3 and Akavar 20/50.
The U.S. Supreme Court has declined to rehear an asbestos injury case the U.S. Court of Appeals for the Third Circuit had remanded for trial in April, paving the way for AstenJohnson Inc.’s six-year-old complaint against its insurers to be heard by a jury.
The plaintiffs in the massive Chinese-made drywall product liability litigation, whose class definition was formerly limited to Virginia, have asked the court for leave to amend their complaint to assert nationwide class claims against Taishan Gypsum Co. Ltd.
The U.S. Food and Drug Administration has warned Procter & Gamble Co.'s CEO that the company is illegally marketing two of its Vicks cold and flu products that contain vitamin C, the agency said Friday.
BP Products North America Inc. has contested a record $87.4 million fine issued by the U.S. Occupational Safety and Health Administration for hundreds of alleged new and ongoing safety violations at a Texas City, Texas, refinery where a 2005 explosion killed 15 people and injured 170 others.
The Flintkote Co.'s suit against Aviva Insurance Co. of Canada to recover for asbestos-related personal injury suits will continue following a judge's refusal to issue summary judgment for the bankrupt asbestos-mining company.
With the first bellwether trial looming in multidistrict litigation over losses related to genetically modified rice in the long-grain rice industry, Bayer CropScience AG has asked a judge to throw out a group of rice farmers' claims for damages allegedly incurred after the 2008-2009 crop year.
British drugmaker Shire PLC has received a subpoena from U.S. investigators seeking documents related to the sales and marketing of three drugs, including Adderall, the company said.
Unilever U.S. Inc. has been hit with a suit accusing the maker of I Can’t Believe It’s Not Butter! and Country Crock brands of cholesterol-free margarines of marketing the butter alternatives as healthy although they contain “dangerous” amounts of trans fat.
A California appeals court has upheld a lower court's denial of class certification to a DirecTV Inc. subscriber alleging the satellite television provider disseminated false advertising to induce customers to buy expensive high-definition services.
A federal judge overseeing multidistrict litigation accusing Ford Motor Co. of knowingly installing a faulty cruise control switch that eventually led to millions of vehicle recalls has clarified a previous order that dismissed several claims related to damages sustained from the defect.
Walt Disney Co. has expanded its refund program for purchasers of its “Baby Einstein” line of educational videos under continued pressure from a children’s advocacy group that claims the videos do not advance infant development as advertised.
Brokerage firm Cantor Fitzgerald & Co. has lost a potential $1 billion in damages now that a judge has rejected its bid to belatedly add airport screening company Globe Aviation Services Corp. to a 9/11-related lawsuit.
Controversial chemical atrazine is among seven pesticides that will undergo preliminary screening by the U.S. Environmental Protection Agency for potential effects on human and animal endocrine systems, the agency announced Thursday.